BRAF, as a serine/threonine kinase, is overactivated by a point mutation, inducing the RAS-RAF-MEK-ERK-MAP kinase pathway and leading to cancer’s proliferation [17,18,19]. The gene discussed is BRAF; the disease is cancer.